活動 & 演講

活動

Our Founder/CEO/CSO, Sareina Wu, and our Director of Scientific communication, Marcus J. Calkins, will present our work as invited expert speakers at the 9th Annual CAR-TCR Summit in Boston, US. (September 17-20, 2024)
閱讀更多
Our COO/CSO, Karen Wen was invited at Taiwan HSCT & Cell Therapy Congress 2024 in NTUH, Taiwan (July 13, 2024)
閱讀更多
GenomeFrontier’s non-viral Quantum pBac was featured in an Genetic Engineering and Biotechnology News article on Streamlining CAR/TCR-T Therapy Manufacturing (April 23, 2024)
閱讀更多
Our Founder/CEO/CSO, Sareina Wu, and BD Director, Ting-Wan, will present as an invited expert speaker at 7th Annual CAR-TCR Summit Europein London, UK (February27-29, 2024)
閱讀更多
GenomeFrontier Partners with BioCina for the Development and Manufacturing of GF-CART01 Cell Therapy Product DNA Materials
閱讀更多